Demand for vaccines for emerging infectious diseases (EIDs) have been increasing at an alarming rate with the rise in the acute outbreaks of the infectious diseases like Zika and Ebola over the past decade. Owing to the health hazards triggered by these diseases, there has been a paradigm shift in the focus of the drug developing companies, which approaches to the issue with the help of clinical trials and novel funding. Having identified the exigency of the health, World Health Organization ... Read more
